At the 2022 ACTRIMS Forum, three groups presented data on acute demyelinating events following COVID-19 vaccination. Read More
Latest News
ACTRIMS Forum 2022 – Update on anti-CD20s and vaccine response
March 1, 2022SPECIAL REPORT
Several studies presented at the ACTRIMS Forum 2022 provided some additional details on the COVID-19 vaccine response among MS patients treated with anti-CD20 therapies. The data suggest that vaccine response may differ somewhat among anti-CD20 agents, which may be related to the depth and/or duration of B cell suppression, the timing of vaccination and patient factors such as age. Read More
‘Breakthrough infection’ uncommon after COVID vaccination
February 24, 2022COVID-19 infections are generally uncommon in healthcare workers and MS patients who have been previously infected or who are fully vaccinated. However, it should be noted that most studies were done prior to the emergence of the Omicron variant. Read More
CLINICAL CASES IN MS – CASE 3: MS-LIKE MRI LESIONS IN A WOMAN WITH MIGRAINE
February 21, 2022Click here to watch Dr. Virender Bhan discuss the case and the responses to the survey.
Elizabeth, 28, is referred by her family practitioner with a note that her MRI report is suggestive of MS. She is married with two children and is currently employed as a middle school teacher. She has a history of episodic migraine but is otherwise healthy. She reports no neurological symptoms. There is no history of recreational drug use. There is no family history of demyelinating diseases including MS. Elizabeth tells you she has a maternal aunt with fibromyalgia. Read More